← Back to Dental References     ↑ View All References

Prescription Drug Abuse Among Dental Patients References

  1. Center for Lawful Access and Abuse Deterrence. (2011). National prescription drug abuse prevention strategy: 2011-2012 update. Retrieved from http://www.claad.org/downloads/CLAAD_Strategy2011_v3.pdf
  2. Coalition Against Insurance Fraud. (2007). Prescription for peril: How insurance fraud finances theft and abuse of addictive prescription drugs. Retrieved from http://www.insurancefraud.org/downloads/drugDiversion.pdf
  3. U.S. Department of Justice, Drug Enforcement Administration, Office of Diversion Control. (2013). Inside diversion control. Retrieved from http://www.deadiversion.usdoj.gov/prog_dscrpt/index.html
  4. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (2011). Results from the 2010 national survey on drug use and health: Summary of national findings. Retrieved from http://www.samhsa.gov/data/nsduh/2k10nsduh/2k10results.htm
  5. National Institutes of Health, National Institute on Drug Abuse. (2011). Prescription drugs: Abuse and addiction. Retrieved from http://www.drugabuse.gov/publications/research-reports/prescription-drugs/preventing-recognizing-prescription-drug-abuse
  6. Executive Office of the President, Office of National Drug Control Policy. (2011). Epidemic: Responding to America’s prescription drug abuse crisis. Retrieved from http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf
  7. Blanco, C., Alderson, D., Ogburn, E., Grant, B. F., Nunes, E. V., Hatzenbuehler, M. L., & Hasin, D. S. (2007). Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug and Alcohol Dependence, 90(2-3), 252-260.
  8. National Institutes of Health, National Institute on Drug Abuse. Drug facts: Prescription and over-the-counter medications. (2013). Retrieved from http://www.drugabuse.gov/publications/drugfacts/prescription-over-counter-medications
  9. National Institutes of Health, National Institute on Drug Abuse. (2007). NIDA launches first large-scale national study to treat addiction to prescription pain medications. Retrieved from http://archives.drugabuse.gov/newsroom/07/NR3-07a.html
  10. Riggs, P. (2008). Non-medical use and abuse of commonly prescribed medications. Current Medical Research and Opinion, 24(3), 869-877.
  11. National Institutes of Health, National Institute on Drug Abuse. (2011). Prescription drugs: Abuse and addiction. Retrieved from http://www.drugabuse.gov/sites/default/files/rrprescription.pdf
  12. Chasen, E. (2007). Purdue Frederick pleads guilty in OxyContin case. New York: Reuters. Retrieved from http://reuters.com/article/2007/05/10/us-oxycontin-misbranding-idUSWBT00695020070510
  13. Mularski, R. A., White-Chi, F., Overbay, D., Miller, L., Asch, S. M., & Ganzini, L. (2006). Measuring pain as the 5th vital sign does not improve quality of pain management. Journal of General Internal Medicine, 21(6), 607-612.
  14. NIDA for Teens: The Science Behind Drug Abuse. Central nervous (CNS) depressant facts. Retrieved from http://teens.drugabuse.gov/peerx/prescription-drug-facts/depressants
  15. Drug-Rehabs.org. The history of drugs. Retrieved from http://www.drug-rehabs.org/history-of-drugs-c.htm
  16. Cornell University Law School, Legal Information Institute. (2013.) Schedules of controlled substances. Retrieved from http://www.law.cornell.edu/uscode/text/21/812
  17. U.S. Department of Justice, Drug Enforcement Administration, Office of Diversion Control. (2013). Controlled substance schedules. Retrieved from http://www.deadiversion.usdoj.gov/schedules/index.html
  18. National Institutes of Health, National Institute on Drug Abuse. (2013). The NIH almanac. Retrieved from http://www.nih.gov/about/almanac/organization/NIDA.htm
  19. U.S. Department of Justice, National Criminal Justice Reference Service. Publications: NCJRS abstract. Retrieved from http://www.ncjrs.gov/App/publications/Abstract.aspx?id=143053
  20. Executive Office of the President, Office of National Drug Control Strategy. (2013). 2013 national drug control strategy. Retrieved from http://www.whitehouse.gov/ondcp/2013-national-drug-control-strategy
  21. National Coalition Against Prescription Drug Abuse. Retrieved from http://www.ncapda.org
  22. National Institutes of Health, National Institute on Drug Abuse. (2011). Topics in brief: Prescription drug abuse. Retrieved from http://www.drugabuse.gov/publications/topics-in-brief/prescription-drug-abuse
  23. McCabel, S. E., West, B. T., Morales, M., Cranford, J. A., & Boyd, C. J. (2007). Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction, 102(12), 1920-1930.
  24. Minnes, S., Lang, A., & Singer, L. (2011). Prenatal tobacco, marijuana, stimulant, and opiate exposure: Outcomes and practice implications. Addiction Science and Clinical Practice, 6(1), 57-70.
  25. National Institutes of Health, National Institute on Drug Abuse, Research Report Series. (2010). Comorbitity: Addiction and other mental illnesses. Retrieved from http://www.drugabuse.gov/sites/default/files/rrcomorbidity.pdf
  26. Regier, D. A., Framer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. Journal of the American Medical Association, 264(19), 2511-2518.
  27. Katz, N. (2010). The role of dentists in preventing prescription opioid abuse. Presentation at the 12th Summit Meeting, Tufts Health Care Institute, Program on Opioid Risk Management. Retrieved from http://www.thci.org/Opioid/mar10docs/KATZ%20THCI%20Intro%203.pdf
  28. Volkow, N. D. (2012). Prescription drug abuse. Testimony to Congress. Retrieved from http://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2010/09/prescription-drug-abuse
  29. Center for Lawful Access and Abuse Deterrence. (2010). National prescription drug abuse prevention strategy 2010. Retrieved from http://claad.org/downloads/2010_National_Strategy.pdf
  30. Harrison Narcotics Tax Act, 1914. (1914). Chapter 1: initial paragraph. Retrieved from http://www.naabt.org/documents/Harrison_Narcotics_Tax_Act_1914.pdf
  31. Harrison Narcotics Tax Act, 1914 (1914). Chapter 1: Section 2(a). Retrieved from http://www.naabt.org/documents/Harrison_Narcotics_Tax_Act_1914.pdf
  32. Wax, P.M. (1995). Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Annals of Internal Medicine, 122(6), 456-461.
  33. Executive Office of the President, Office of National Drug Control Policy. (2011). About ONDCP. Retrieved from http://www.whitehouse.gov/ondcp/about
  34. Executive Office of the President, Office of National Drug Control Policy. (2011). Fact sheet: A response to the epidemic of prescription drug abuse. Retrieved from http://www.whitehouse.gov/sites/default/files/ondcp/Fact_Sheets/prescription_drug_abuse_fact_sheet_4-25-11.pdf
  35. The American Academy of Pain Medicine. (2011). White House announces the first national drug abuse prevention plan. Retrieved from http://www.painmed.org/PatientCenter/PreventDrugAbuse/prescription-drug-abuse-prevention-plan/
  36. National Institutes of Health, National Institute on Drug Abuse. (2013). About NIDA. Retrieved from http://www.drugabuse.gov/about-nida
  37. United Nations Office on Drugs and Crime. (2011). The non-medical use of prescription drugs: Policy direction issues, discussion paper. Retrieved from http://www.unodc.org/docs/youthnet/Final_Prescription_Drugs_Paper.pdf
  38. Center for Lawful Access and Abuse Deterrence. Retrieved from http://www.claad.org/
  39. Center for Lawful Access and Abuse Deterrence. Policy activity. Retrieved from http://www.claad.org/resources/policy-activity
  40. National Rx Drug Abuse Summit. Retrieved from http://nationalrxdrugabusesummit.org/
  41. O’Toole, J. (2012). How prescription drug abuse costs you money. CNNMoney. Retrieved from http://money.cnn.com/2012/02/22/news/economy/prescription_drug_abuse/index.htm
  42. Hansen, R. N., Oster, G., Edelsberg, J., Woody, G. E., & Sullivan, S. D. (2011). Economic costs of nonmedical use of prescription opioids. Clinical Journal of Pain, 27(3), 194-202.
  43. White, A. G., Birnbaum, H. G., Mareva, M. N., Daher, M., Vallow, S., Schein, J., & Katz, N. (2005). Direct costs of opioid abuse in an insured population in the United States. Journal of Managed Care Pharmacy, 11(6), 469-479.
  44. Birnbaum, H. G., White, A. G., Schiller, M., Waldman, T., Cleveland, J. M., & Roland, C. L. (2011). Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Medicine, 12(4), 657-67. doi:10.1111/j.1526-4637.2011.01075.x.
  45. Executive Office of the President, Office of National Drug Control Policy. Special populations. Retrieved from http://www.whitehouse.gov/ondcp/special-populations
  46. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2010). Results from the 2009 national survey on drug use and health: Volume I. Summary of national findings. Retrieved from http://oas.samhsa.gov/NSDUH/2k9NSDUH/2k9Results.htm
  47. Alliance of States with Prescription Drug Monitoring Programs. (2012). Did you know? NIDA’s PEERx. The Alliance Monitor. Retrieved from http://www.pmpalliance.org/content/did-you-know-1
  48. National Institutes of Health, National Institute on Drug Abuse. (2011). Facts on prescription and over-the-counter drugs. Retrieved from http://teens.drugabuse.gov/sites/default/files/peerx/pdf/PEERx_Toolkit_FactSheets_OTC_012313.pdf
  49. Community Anti-Drug Coalitions of America in collaboration with the ONDCP’s National Youth Anti-Drug Media Campaign. (2008). Strategizer 52 – Teen prescription drug abuse: An emerging threat. Retrieved from http://www.cadca.org/resources/detail/teen-prescription-drug-abuse-emerging-threat
  50. Kilpatrick, D. G., Acierno, R., Saunders, B., Resnick, H. S., Best, C. L., & Schnurr, P. P. (2000). Risk factors for adolescent substance abuse and dependence: Data from a national sample. Journal of Consulting and Clinical Psychology, 68(1), 19-30. doi:10.1037/0022-006X.68.1.19
  51. Volkow, N. D. (2008). Statement by Nora D. Volkow, MD, Director National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services on scientific research on prescription drug abuse before Judiciary Committee, Subcommittee on Crime and Drugs, U.S. Senate. Retrieved from http://www.hhs.gov/asl/testify/2008/03/t20080312a.html
  52. Arria, A. M., Caldeira, K. M., Kasperski, S. J., O’Grady, K. E., Vincent, K. B., Griffiths, R. R., & Wish, E. D. (2010). Increased alcohol consumption, non-medical prescription drug use, and illicit drug use are associated with energy drink consumption among college students. Journal of Addiction Medicine, 4(2), 74-80. doi:10.1097/ADM.0b013e3181aa8dd4
  53. Arria, A. M., O’Grady, K. E., Caldeira, K. M., Vincent, K. B., & Wish, E. D. (2008). Non-medical use of prescription stimulants and analgesics: Associations with social and academic behaviors among college students. Journal of Drug Issues, 38(4), 1045-1060.
  54. Arria, A. M., Caldeira, K. M., O’Grady, K. E., Vincent, K. B., Johnson, E. P., & Wish, E. D. (2008). Non-medical use of prescription stimulants among college students: Associations with attention-deficit hyperactivity disorder and polydrug use. Phamacotherapy, 28(2), 156-169.
  55. McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. (2005). Nonmedical use of prescription stimulants among U.S. college students: Prevalence and correlates from a national survey. Addiction, 100(1), 96-106.
  56. McCabe, S. E., Teter, C. J., Boyd, C. J., Knight, J. R., & Wechsler, H. (2005). Nonmedical use of prescription opioids among U.S. college students: Prevalence and correlates from a national survey. Addictive Behavior, 30(4), 789-805.
  57. National Institutes of Health, National Institute on Drug Abuse. (n.d.). Commonly abused drugs: Health effects. Retrieved from http://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs/health-effects
  58. Bray, R. M., Pemberton, M. R., Lane, M. E., Hourani, L. L., Mattiko, M. J., & Babeu, L. A. (2010). Substance use and mental health trends among U.S. military active duty personnel: Key findings from the 2008 DoD health behavior survey. Retrieved from http://www.dtic.mil/cgi-bin/GetTRDoc?AD=ADA523045
  59. Institute of Medicine of the National Academies. (2012). Substance use disorders in the U.S. Armed Forces. Retrieved from http://www.iom.edu/Reports/2012/Substance-Use-Disorders-in-the-US-Armed-Forces.aspx
  60. National Institutes of Health, National Institute on Drug Abuse. (2011). Substance abuse among the military, veterans, and their families. Retrieved from http://www.drugabuse.gov/publications/topics-in-brief/substance-abuse-among-military-veterans-their-families
  61. National Institutes of Health, National Institute on Drug Abuse. Prescription drugs: Abuse and addiction, older adults. Retrieved from http://www.drugabuse.gov/publications/research-reports/prescription-drugs/trends-in-prescription-drug-abuse/older-adults
  62. Oakley, M., O’Donnell, J. A., Moore, P. A., & Martin, J. P. (2011). The rise in prescription drug abuse: Raising awareness in the dental community. Compendium of Continuing Education in Dentistry, 32(6), 14-22.
  63. Executive Office of the President, Office of National Drug Control Policy. Collaborating with Native Americans and Alaskan natives. Retrieved from http://www.whitehouse.gov/ondcp/native-americans-and-alaskan-indians
  64. National Institutes of Health, National Institute on Drug Abuse. (n.d.). Prescription drugs: Abuse and addiction: Gender differences. Retrieved from http://www.drugabuse.gov/publications/research-reports/prescription-drugs/trends-in-prescription-drug-abuse/gender-differences
  65. Jamison, R. N., Butler, S. F., Budman, S. H., Edwards, R. R., & Wasan, A. D. (2010). Gender differences in risk factors for aberrant prescription opioid use. Journal of Pain, 11(4), 312-320.
  66. Pergolizzi, J. V., Gharibo, C., Passik, S., Labhsetwar, S., Taylor, R., Pergolizzi, J. S., & Muller-Schwefe, G. (2012). Dynamic risk factors in the misuse of opioid analgesics. Journal of Psychosomatic Research, 72(6), 443-451.
  67. National Institutes of Health, National Institute on Drug Abuse. (2003). Preventing drug abuse among children and adolescents (in brief). Retrieved from http://www.drugabuse.gov/publications/preventing-drug-abuse-among-children-adolescents/chapter-1-risk-factors-protective-factors/when-how-does-drug-ab
  68. U.S. Department of Justice, Drug Enforcement Administration. (n.d.). Diversion control/ prescription drug abuse. Retrieved from http://www.justice.gov/dea/ops/diversion.shtml
  69. Burke, J. (2005). Drug diversion: The scope of the problem. National Association of Drug Diversion Investigators. Retrieved from http://naddi.org/aws/NADDI/asset_manager/get_file/3143
  70. National Institutes of Health, National Institute on Drug Abuse. (2011). Analysis of opioid prescription practices finds areas of concern. Retrieved from http://www.drugabuse.gov/news-events/news-releases/2011/04/analysis-opioid-prescription-practices-finds-areas-concern
  71. Volkow, N. D., McLellan, T. A., Cotto, J. H., Karithanom, M., & Weiss, S. (2011). Characteristics of opioid prescriptions in 2009. Journal of the American Medical Association, 305(13), 1299-1301.
  72. Bates, C., Laciak, R., Sothwick, A., & Bishoff, J. (2011). Overprescription of postoperative narcotics: A look at postoperative pain medication delivery, consumption and disposal in urological practice. Journal of Urology, 185(2), 551-555.
  73. American Dental Association. (n.d.). Prescription drug abuse. Retrieved from http://www.ada.org/7541.aspx
  74. Academy of Managed Care Pharmacy. (2012). Practice advisory on collaborative drug therapy management. Retrieved from http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=14710
  75. Brushwood, D. B. (2001). Collegial accountability and the expanding role of pharmacists in the management of chronic pain. Journal of Law, Medicine, & Ethics, 29(1), 69-93.
  76. The National Center on Addiction and Substance Abuse at Columbia University. (2005). Under the counter: The diversion and abuse of controlled prescription drugs in the U.S. Retrieved from http://www.casacolumbia.org
  77. American Dental Association. (2005). Statement on the use of opioids in the treatment of dental pain. Retrieved from http://www.ada.org/7578.aspx
  78. Ilgen, M., Edwards, P., Kleinberg, F., Bohnert, A., Barry, K., & Blow, F. C. (2012). The prevalence of substance abuse among patients at a dental school clinic in Michigan. Journal of the American Dental Association, 143(8), 890-896.
  79. American Dental Association. (2005). Statement on provision of dental treatment for patients with substance use disorders. Retrieved from http://www.ada.org/7580.aspx
  80. Webster, L. R., & Webster, R. M. (2005). Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool. Pain Medicine, 6(6), 432-442.
  81. American College of Preventive Medicine. (2011). Use, abuse, misuse, and disposal of prescription pain medication. Retrieved from http://www.acpm.org/?UseAbuseRxClinRef
  82. U.S. Department of Justice, Drug Enforcement Administration, Office of Diversion Control. (1999). Don’t be scammed by a drug abuser. Retrieved from http://www.deadiversion.usdoj.gov/pubs/brochures/drugabuser.htm
  83. Substance Abuse and Mental Health Services Administration. (2011). Screening, brief intervention and referral to treatment (SBIRT) in behavioral health care. Retrieved from http://www.samhsa.gov/prevention/sbirt/SBIRTwhitepaper.pdf
  84. National Institutes of Health, National Institute on Drug Abuse. (2012). NM ASSIST: Screening for tobacco, alcohol, and other drug use. Retrieved from http://www.drugabuse.gov/nidamed/nm-assist-screening-tobacco-alcohol-other-drug-use
  85. National Institutes of Health, National Institute on Drug Abuse. (2012). NIDA drug use screening tool quick screen: For all patients. Retrieved from http://www.drugabuse.gov/nidamed/tool-resources-your-practice/additional-screening-resources
  86. Substance Abuse and Mental Health Services Administration. (2006). Screening and assessment for family engagement, retention, and recovery (SAFERR): Appendix D: Examples of screening and assessment tools for substance use disorders. Retrieved from http://www.ncsacw.samhsa.gov/files/SAFERR_AppendixD.pdf
  87. Johns Hopkins Medicine. (1984). CAGE substance abuse screening tool. Retrieved from http://www.hopkinsmedicine.org/johns_hopkins_healthcare/downloads/CAGE%20Substance%20Screening%20Tool.pdf
  88. American Dental Association. (2012). Principles of ethics and code of professional conduct. Retrieved from http://www.ada.org/194.aspx
  89. Wentworth, R. B. (2008). What should I do when I suspect a patient may be abusing prescription drugs? Journal of the American Dental Association, 139(5), 623-624.
  90. Becker, D. E. (2010). Pain management part I: Managing acute and postoperative dental pain. Anesthesia Progress, 57, 67-79.
  91. Mehlisch, D. R., Aspley, S., Daniels, S. E., Southerden, K. A., & Christensen, K. S. (2010). A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: A multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study. Clinical Therapeutics, 32(6), 1033-1049.
  92. Merry, A. F., Gibbs, R. D., Edwards, J., Ting, G. S., Frampton, C., Davies, E., & Anderson, B. J. (2010). Combined acetaminophen and ibuprofen for pain relief after oral surgery in adults: A randomized controlled trial. British Journal of Anesthesiology, 104(1), 80-88.
  93. Denisco, R. C., Kenna, G. A., O’Neil, M. G., Kulich, R. J., Moore, P. A., Kane, W. T., . . . Katz, N. P. (2011). Prevention of prescription opioid abuse: The role of the dentist. Journal of the American Dental Association, 142(7), 800-810.
  94. National Council on Patient Information and Education. (2008). Tips on safe storage and disposal of your prescription medicines. Retrieved from http://www.talkaboutrx.org/documents/safe_storage.pdf
  95. Substance Abuse and Mental Health Services Adminstration. (2013). Behavioral health treatment services locator. Retrieved from http://findtreatment.samhsa.gov/
  96. Prescribers’ Clinical Support System for Opioid Therapies. (n.d.). Prescribers’ clinical support system for opioid therapies training. Retrieved from http://www.pcss-o.org/about
  97. U.S. Food and Drug Administration. (2013). Approved risk evaluation and mitigation strategies (REMS). Retrieved from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111350.htm
  98. Kraman, P. (2004). Trends alert: Prescription drug diversion. Retrieved from http://www.csg.org/knowledgecenter/docs/TA0404DrugDiversion.pdf
  99. Finklea, K. M., Bagalman, E., & Sacco, L. N. (2013). Prescription drug monitoring programs, Congressional Research Service. Retrieved from http://www.fas.org/sgp/crs/misc/R42593.pdf
  100. Clark, T., Eadie, J., Kreiner, P., & Strickler, J. (2012). Prescription drug monitoring programs: An assessment of the evidence for best practices. Retrieved from http://www.pdmpexcellence.org/sites/all/pdfs/Brandeis_PDMP_Report_final.pdf
  101. Tufts Health Care Institute Program on Opioid Risk Management. (2010). The role of dentists in preventing opioid abuse: Executive summary. Retrieved from http://www.thci.org/opioid/mar10docs/executivesummary.pdf